首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi

市場調查報告書

商品編碼

1370547

反義與 RNAi 治療市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Antisense & RNAi Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: 2023年10月15日 | 出版商:

IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

概要

市場概況：

2022年，全球反義和RNAi治療市場規模達到15億美元。展望未來，IMARC Group預計到2028年市場規模將達到25億美元，2023-2028年年複合成長率（CAGR）為8.3%。

反義療法是透過單股 DNA 寡核苷酸對基因表現進行選擇性和序列特異性抑制。它調節細胞功能和分裂，並可以調節細胞對內部和外部壓力和刺激的反應。它也用於治療肌萎縮側索硬化症、亨廷頓舞蹈症和阿茲海默症。另一方面，RNA 干擾 (RNAi) 療法由雙股 RNA (dsRNA) 觸發，並響應 dsRNA 導致單股目標 RNA 的序列特異性核糖核酸 (mRNA) 分解。它用於治療各種呼吸系統疾病，例如慢性阻塞性肺病（COPD）和氣喘。 RNAi 療法也有助於預防導致疾病或促進疾病發展的特定基因的產生。

反義和 RNAi 治療市場趨勢：

對反義和 RNAi 療法治療罕見神經退化性疾病（例如遺傳性 ATTR 澱粉樣變性）的需求不斷成長，這是推動市場的關鍵因素之一。除此之外，全球範圍內透過故障基因來調節基因表現的疾病管理需求不斷增加。這與蓬勃發展的醫療保健行業一起促進了市場的成長。此外，主要市場參與者正在廣泛投資於研發（R&D）活動，以開發基於反義技術的分子。他們也與致力於藥物傳遞的合約研究組織（CRO）合作，這正在加強市場的成長。此外，對反義RNA預防疾病發作和減少疾病進展的需求不斷成長，正在對市場產生積極影響。除此之外，治療和預防癌症、人類免疫缺陷病毒（HIV）和其他由變異病毒引起的疾病等疾病的需求不斷成長，也推動了市場的成長。

本報告回答的關鍵問題

全球反義和RNAi治療市場有多大？
2023-2028年全球反義和RNAi治療市場的預期成長率是多少？
推動全球反義和 RNAi 治療市場的關鍵因素是什麼？
COVID-19 對全球反義和 RNAi 治療市場有何影響？
基於此技術的全球反義和 RNAi 治療市場的詳細情形如何？
根據給藥途徑，全球反義和 RNAi 治療市場的詳細情形如何？
全球反義和RNAi治療市場的關鍵區域有哪些？
誰是全球反義和 RNAi 治療市場的主要參與者/公司？

腫瘤學
- 市場走向
- 市場預測
心血管疾病 (CVD)
- 市場走向
- 市場預測
呼吸系統疾病
- 市場走向
- 市場預測
腎臟疾病
- 市場走向
- 市場預測
神經退化性疾病
- 市場走向
- 市場預測
遺傳性疾病
- 市場走向
- 市場預測
傳染性疾病
- 市場走向
- 市場預測
其他
- 市場走向
- 市場預測

第 9 章：按地區分類的市場區隔

北美洲
- 美國
  - 市場走向
  - 市場預測
- 加拿大
  - 市場走向
  - 市場預測
亞太
- 中國
  - 市場走向
  - 市場預測
- 日本
  - 市場走向
  - 市場預測
- 印度
  - 市場走向
  - 市場預測
- 韓國
  - 市場走向
  - 市場預測
- 澳洲
  - 市場走向
  - 市場預測
- 印尼
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
歐洲
- 德國
  - 市場走向
  - 市場預測
- 法國
  - 市場走向
  - 市場預測
- 英國
  - 市場走向
  - 市場預測
- 義大利
  - 市場走向
  - 市場預測
- 西班牙
  - 市場走向
  - 市場預測
- 俄羅斯
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
拉丁美洲
- 巴西
  - 市場走向
  - 市場預測
- 墨西哥
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
中東和非洲
- 市場走向
- 按國家/地區分類的市場細分
- 市場預測

第 10 章：SWOT 分析

概述
優勢
弱點
機會
威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

概述
買家的議價能力
供應商的議價能力
競爭程度
新進入者的威脅
替代品的威脅

第 13 章：價格分析

第14章：競爭格局

市場結構
關鍵參與者
關鍵參與者簡介
- Alnylam Pharmaceuticals Inc.
- Arbutus Biopharma Corporation
- Arrowhead Pharmaceuticals Inc.
- Benitec Biopharma Ltd.
- Bio-Path Holdings Inc.
- Dicerna Pharmaceuticals Inc. (Novo Nordisk A/S)
- Ionis Pharmaceuticals Inc.
- OliX Pharmaceuticals Inc.
- Phio Pharmaceuticals Corp.
- Sarepta Therapeutics Inc.
- Silence Therapeutics
- Sirnaomics Inc.

簡介目錄圖表

Product Code: SR112023A6549

Abstract

Market Overview:

The global antisense & RNAi therapeutics market size reached US$ 1.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2028, exhibiting a growth rate (CAGR) of 8.3% during 2023-2028.

Antisense therapy is the selective and sequence-specific inhibition of gene expression by single-stranded DNA oligonucleotides. It regulates cell function and division and can modulate cellular responses to internal and external stresses and stimuli. It is also used to treat amyotrophic lateral sclerosis and Huntington's and Alzheimer's disease. On the other hand, RNA interference (RNAi) therapy is triggered by double-stranded RNA (dsRNA) and causes sequence-specific ribonucleic acid (mRNA) degradation of single-stranded target RNAs in response to dsRNA. It is employed for treating various respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and asthma. RNAi therapy also assists in preventing the production of specific genes that cause diseases or contribute to the growth of diseases.

Antisense & RNAi Therapeutics Market Trends:

The growing demand for antisense and RNAi therapeutics to treat uncommon neurodegenerative diseases, such as hereditary ATTR amyloidosis, represents one of the key factors driving the market. Besides this, there is a rise in the demand for disease management to regulate gene expression by malfunctioning genes across the globe. This, along with the burgeoning healthcare industry, is contributing to the growth of the market. Moreover, key market players are extensively investing in research and development (R&D) activities to develop molecules based on antisense technology. They are also collaborating with contract research organizations (CROs) working on drug delivery, which is strengthening the growth of the market. In addition, the growing demand for antisense RNA to prevent disease onset and reduce disease progression is positively influencing the market. Apart from this, the rising need for curing and preventing diseases, such as cancer, human immunodeficiency virus (HIV), and other diseases caused by mutating viruses is bolstering the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global antisense & RNAi therapeutics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on technology, route of administration and application.

Breakup by Technology:

RNA Interference

siRNA

miRNA

Antisense RNA

Breakup by Route of Administration:

Intravenous Route

Subcutaneous Route

Intrathecal Route

Pulmonary Delivery

Intraperitoneal Injection

Others

Breakup by Application:

Oncology

Cardiovascular Diseases (CVDs)

Respiratory Disorders

Renal Diseases

Neurodegenerative Disorders

Genetic Disorders

Infectious Diseases

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Alnylam Pharmaceuticals Inc., Arbutus Biopharma Corporation, Arrowhead Pharmaceuticals Inc., Benitec Biopharma Ltd., Bio-Path Holdings Inc., Dicerna Pharmaceuticals Inc. (Novo Nordisk A/S), Ionis Pharmaceuticals Inc., OliX Pharmaceuticals Inc., Phio Pharmaceuticals Corp., Sarepta Therapeutics Inc., Silence Therapeutics and Sirnaomics Inc.

Key Questions Answered in This Report

1. How big is the global antisense & RNAi therapeutics market?
2. What is the expected growth rate of the global antisense & RNAi therapeutics market during 2023-2028?
3. What are the key factors driving the global antisense & RNAi therapeutics market?
4. What has been the impact of COVID-19 on the global antisense & RNAi therapeutics market?
5. What is the breakup of the global antisense & RNAi therapeutics market based on the technology?
6. What is the breakup of the global antisense & RNAi therapeutics market based on the route of administration?
7. What are the key regions in the global antisense & RNAi therapeutics market?
8. Who are the key players/companies in the global antisense & RNAi therapeutics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Antisense & RNAi Therapeutics Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Technology

6.1 RNA Interference
- 6.1.1 Market Trends
- 6.1.2 Key Segments
  - 6.1.2.1 siRNA
  - 6.1.2.2 miRNA
- 6.1.3 Market Forecast
6.2 Antisense RNA
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Route of Administration

7.1 Intravenous Route
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Subcutaneous Route
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Intrathecal Route
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Pulmonary Delivery
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Intraperitoneal Injection
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast

8 Market Breakup by Application

8.1 Oncology
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Cardiovascular Diseases (CVDs)
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Respiratory Disorders
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Renal Diseases
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Neurodegenerative Disorders
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
8.6 Genetic Disorders
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
8.7 Infectious Diseases
- 8.7.1 Market Trends
- 8.7.2 Market Forecast
8.8 Others
- 8.8.1 Market Trends
- 8.8.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Alnylam Pharmaceuticals Inc.
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
  - 14.3.1.4 SWOT Analysis
- 14.3.2 Arbutus Biopharma Corporation
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
  - 14.3.2.3 Financials
  - 14.3.2.4 SWOT Analysis
- 14.3.3 Arrowhead Pharmaceuticals Inc.
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
- 14.3.4 Benitec Biopharma Ltd.
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
  - 14.3.4.3 Financials
  - 14.3.4.4 SWOT Analysis
- 14.3.5 Bio-Path Holdings Inc.
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 Financials
- 14.3.6 Dicerna Pharmaceuticals Inc. (Novo Nordisk A/S)
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
- 14.3.7 Ionis Pharmaceuticals Inc.
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 Financials
  - 14.3.7.4 SWOT Analysis
- 14.3.8 OliX Pharmaceuticals Inc.
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 Financials
- 14.3.9 Phio Pharmaceuticals Corp.
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
  - 14.3.9.3 Financials
- 14.3.10 Sarepta Therapeutics Inc.
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
  - 14.3.10.3 Financials
  - 14.3.10.4 SWOT Analysis
- 14.3.11 Silence Therapeutics
  - 14.3.11.1 Company Overview
  - 14.3.11.2 Product Portfolio
  - 14.3.11.3 Financials
- 14.3.12 Sirnaomics Inc.
  - 14.3.12.1 Company Overview
  - 14.3.12.2 Product Portfolio

簡介目錄圖表

List of Figures

Figure 1: Global: Antisense & RNAi Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Antisense & RNAi Therapeutics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Antisense & RNAi Therapeutics Market: Breakup by Technology (in %), 2022
Figure 5: Global: Antisense & RNAi Therapeutics Market: Breakup by Route of Administration (in %), 2022
Figure 6: Global: Antisense & RNAi Therapeutics Market: Breakup by Application (in %), 2022
Figure 7: Global: Antisense & RNAi Therapeutics Market: Breakup by Region (in %), 2022
Figure 8: Global: Antisense & RNAi Therapeutics (RNA Interference) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Antisense & RNAi Therapeutics (RNA Interference) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Antisense & RNAi Therapeutics (Antisense RNA) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Antisense & RNAi Therapeutics (Antisense RNA) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Antisense & RNAi Therapeutics (Intravenous Route) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Antisense & RNAi Therapeutics (Intravenous Route) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Antisense & RNAi Therapeutics (Subcutaneous Route) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Antisense & RNAi Therapeutics (Subcutaneous Route) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Antisense & RNAi Therapeutics (Intrathecal Route) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Antisense & RNAi Therapeutics (Intrathecal Route) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Antisense & RNAi Therapeutics (Pulmonary Delivery) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Antisense & RNAi Therapeutics (Pulmonary Delivery) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Antisense & RNAi Therapeutics (Intraperitoneal Injection) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Antisense & RNAi Therapeutics (Intraperitoneal Injection) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Antisense & RNAi Therapeutics (Other Routes of Administration) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Antisense & RNAi Therapeutics (Other Routes of Administration) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Antisense & RNAi Therapeutics (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Antisense & RNAi Therapeutics (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Antisense & RNAi Therapeutics (Cardiovascular Diseases (CVDs)) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Antisense & RNAi Therapeutics (Cardiovascular Diseases (CVDs)) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Antisense & RNAi Therapeutics (Respiratory Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Antisense & RNAi Therapeutics (Respiratory Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Antisense & RNAi Therapeutics (Renal Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Antisense & RNAi Therapeutics (Renal Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Antisense & RNAi Therapeutics (Neurodegenerative Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Antisense & RNAi Therapeutics (Neurodegenerative Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Global: Antisense & RNAi Therapeutics (Genetic Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Global: Antisense & RNAi Therapeutics (Genetic Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Global: Antisense & RNAi Therapeutics (Infectious Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Global: Antisense & RNAi Therapeutics (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Global: Antisense & RNAi Therapeutics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Global: Antisense & RNAi Therapeutics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: North America: Antisense & RNAi Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: North America: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: United States: Antisense & RNAi Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: United States: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Canada: Antisense & RNAi Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Canada: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Asia-Pacific: Antisense & RNAi Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Asia-Pacific: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: China: Antisense & RNAi Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: China: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Japan: Antisense & RNAi Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Japan: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: India: Antisense & RNAi Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: India: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: South Korea: Antisense & RNAi Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: South Korea: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Australia: Antisense & RNAi Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Australia: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Indonesia: Antisense & RNAi Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Indonesia: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Others: Antisense & RNAi Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Others: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Europe: Antisense & RNAi Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Europe: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Germany: Antisense & RNAi Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Germany: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: France: Antisense & RNAi Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: France: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: United Kingdom: Antisense & RNAi Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: United Kingdom: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Italy: Antisense & RNAi Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Italy: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Spain: Antisense & RNAi Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Spain: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Russia: Antisense & RNAi Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Russia: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Others: Antisense & RNAi Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Others: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Latin America: Antisense & RNAi Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Latin America: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Brazil: Antisense & RNAi Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: Brazil: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Mexico: Antisense & RNAi Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 83: Mexico: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: Others: Antisense & RNAi Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 85: Others: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 86: Middle East and Africa: Antisense & RNAi Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 87: Middle East and Africa: Antisense & RNAi Therapeutics Market: Breakup by Country (in %), 2022
Figure 88: Middle East and Africa: Antisense & RNAi Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 89: Global: Antisense & RNAi Therapeutics Industry: SWOT Analysis
Figure 90: Global: Antisense & RNAi Therapeutics Industry: Value Chain Analysis
Figure 91: Global: Antisense & RNAi Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Antisense & RNAi Therapeutics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Antisense & RNAi Therapeutics Market Forecast: Breakup by Technology (in Million US$), 2023-2028
Table 3: Global: Antisense & RNAi Therapeutics Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
Table 4: Global: Antisense & RNAi Therapeutics Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 5: Global: Antisense & RNAi Therapeutics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Antisense & RNAi Therapeutics Market: Competitive Structure
Table 7: Global: Antisense & RNAi Therapeutics Market: Key Players

02-2729-4219

+886-2-2729-4219